About Rohit Sharma
Form D filings for Enveda Therapeutics from 2020 to 2023 list Rohit Sharma as director.
Rohit Sharma first appears on SEC filings in 2020.
Experience
This experience comes from SEC filings. The years are when the filings name Rohit Sharma in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Rohit Sharma works with at each company, as listed on that company's latest Form D.
Enveda Therapeutics, Inc. · Form D, Mar 7, 2023
ZD
Zavain Dar
Director
BB
Bruce Beutel
Director
DW
Daniel Wee
Executive officer
SV
Shaquille Vayda
Director
VC
Viswa Colluru
Chief Executive Officer and director